Development of inducible genetic systems to finely tune efficacy of InhA-targeting anti-tuberculous drugs
This study establishes inducible CRISPRi-based genetic systems in mycobacteria to dynamically fine-tune the expression of InhA-targeting drug pathways, thereby creating conditional hypomorphs that exhibit tunable resistance or hypersensitivity to isoniazid and ethionamide for the development of next-generation anti-tuberculosis therapies.